#pharmaceutically

CAS No.: 6138 23 4

D(+)-TREHALOSE DIHYDRATE (FOR INJECTION) CAS NO.: 6138-23-4

AVT trehalose dihydrate (for injection) is commonly used in lyophilized protective agent, lipid nanoparticles and mRNA stabilizer and cryoprotectant. Highly cost-effective, Injection grade, product quality in line with ChP, USP, JP, EP standards,CAS NO.: 6138-23-4. Registered with the US FDA, DMF No.034401 and 035566.

D(+)-TREHALOSE DIHYDRATE (FOR INJECTION) KEY BENEFITS

AVT introduces the specifications of trehalose dihydrate like trehalose dihydrate molecular weight. It also can called alpha alpha trehalose dihydrate and crystalline trehalose dihydrate has many benefits.

Highly cost-effective, low endotoxin (<0.1IU/g), injection grade.

Comply with the national pharmacopeia standards, ChP, JP, EP, and our trehalose dihydrate also meet USP and GMP standards.

D(+)-TREHALOSE DIHYDRATE (FOR INJECTION) SPECIFICATIONS

Product Name:

D(+)-Trehalose dihydrate (for injection)

Chemical Name:

α-D-glucopyranosyl-α-D-glucopyranoside dihydrate

Content Determination:

0.993

CAS No.

6138-23-4

FDA DMF No.

DMF No. 034401

Molecular Formula:

C12H22O11·2H2O

Molecular Weight:

378.33

Properties:

crystalline powder

Specific Rotation:

+198.8°

Acidity:

6

Chloride:

the regulations

Sulfate:

the regulations

Soluble Starch:

in line with regulations

Residue on Ignition:

ignition: 0.04%

Heavy Metals:

in compliance with regulations

Moisture:

9.50%

Related Substances:

total impurities 0.06%, glucose not detected, maltotriose 0.06%, the largest unknown single impurities not detected

Microbial Limit:

sterile

Bacterial Endotoxin:

<0.1IU/g

Nitrogen:

line with regulations

Determination of Content:

99.30%

Solubility:

soluble in water, soluble in hot ethanol, slightly soluble in methanol, insoluble in ether and acetone

Storage: